IMCR logo

Immunocore Holdings plc (IMCR) EBITDA

Annual EBITDA:

-$29.89M+$21.76M(+42.13%)
December 31, 2024

Summary

  • As of today, IMCR annual EBITDA is -$29.89 million, with the most recent change of +$21.76 million (+42.13%) on December 31, 2024.
  • During the last 3 years, IMCR annual EBITDA has risen by +$136.83 million (+82.07%).
  • IMCR annual EBITDA is now at all-time high.

Performance

IMCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

Quarterly EBITDA:

-$6.33M+$7.93M(+55.58%)
September 30, 2025

Summary

  • As of today, IMCR quarterly EBITDA is -$6.33 million, with the most recent change of +$7.93 million (+55.58%) on September 30, 2025.
  • Over the past year, IMCR quarterly EBITDA has increased by +$1.21 million (+16.03%).
  • IMCR quarterly EBITDA is now -128.48% below its all-time high of -$2.77 million, reached on March 31, 2025.

Performance

IMCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

TTM EBITDA:

-$41.49M+$1.21M(+2.83%)
September 30, 2025

Summary

  • As of today, IMCR TTM EBITDA is -$41.49 million, with the most recent change of +$1.21 million (+2.83%) on September 30, 2025.
  • Over the past year, IMCR TTM EBITDA has increased by +$24.64 million (+37.26%).
  • IMCR TTM EBITDA is now -44.98% below its all-time high of -$28.61 million, reached on December 31, 2020.

Performance

IMCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IMCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+42.1%+16.0%+37.3%
3Y3 Years+82.1%+28.5%+50.7%
5Y5 Years+79.9%--

IMCR EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+82.1%-128.5%+75.1%-4.4%+50.7%
5Y5-Yearat high+82.1%-128.5%+87.0%-45.0%+76.4%
All-TimeAll-Timeat high+82.1%-128.5%+87.0%-45.0%+76.4%

IMCR EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$6.33M(+55.6%)
-$41.49M(+2.8%)
Jun 2025
-
-$14.26M(-414.4%)
-$42.69M(+1.8%)
Mar 2025
-
-$2.77M(+84.7%)
-$43.47M(+34.3%)
Dec 2024
-$29.89M(+42.1%)
-$18.12M(-140.2%)
-$66.17M(-0.1%)
Sep 2024
-
-$7.54M(+49.8%)
-$66.12M(+4.9%)
Jun 2024
-
-$15.04M(+40.9%)
-$69.50M(-3.4%)
Mar 2024
-
-$25.46M(-40.9%)
-$67.22M(-20.8%)
Dec 2023
-$51.65M(-71.4%)
-$18.07M(-65.5%)
-$55.63M(-16.3%)
Sep 2023
-
-$10.92M(+14.5%)
-$47.85M(-4.5%)
Jun 2023
-
-$12.77M(+7.9%)
-$45.79M(-15.2%)
Mar 2023
-
-$13.87M(-34.8%)
-$39.73M(+13.0%)
DateAnnualQuarterlyTTM
Dec 2022
-$30.14M(+81.9%)
-$10.29M(-16.2%)
-$45.69M(+45.7%)
Sep 2022
-
-$8.86M(-31.9%)
-$84.09M(+27.2%)
Jun 2022
-
-$6.72M(+66.1%)
-$115.48M(+25.3%)
Mar 2022
-
-$19.82M(+59.3%)
-$154.58M(+12.2%)
Dec 2021
-$166.72M(-62.5%)
-$48.69M(-21.0%)
-$176.11M(-12.9%)
Sep 2021
-
-$40.25M(+12.2%)
-$156.04M(-34.8%)
Jun 2021
-
-$45.82M(-10.8%)
-$115.79M(-65.5%)
Mar 2021
-
-$41.36M(-44.5%)
-$69.97M(-144.5%)
Dec 2020
-$102.59M(+30.9%)
-$28.61M(+11.7%)
-$28.61M(+11.7%)
Dec 2019
-$148.40M(-45.0%)
-$32.41M
-$32.41M
Dec 2018
-$102.31M
-
-

FAQ

  • What is Immunocore Holdings plc annual EBITDA?
  • What is the all-time high annual EBITDA for Immunocore Holdings plc?
  • What is Immunocore Holdings plc annual EBITDA year-on-year change?
  • What is Immunocore Holdings plc quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Immunocore Holdings plc?
  • What is Immunocore Holdings plc quarterly EBITDA year-on-year change?
  • What is Immunocore Holdings plc TTM EBITDA?
  • What is the all-time high TTM EBITDA for Immunocore Holdings plc?
  • What is Immunocore Holdings plc TTM EBITDA year-on-year change?

What is Immunocore Holdings plc annual EBITDA?

The current annual EBITDA of IMCR is -$29.89M

What is the all-time high annual EBITDA for Immunocore Holdings plc?

Immunocore Holdings plc all-time high annual EBITDA is -$29.89M

What is Immunocore Holdings plc annual EBITDA year-on-year change?

Over the past year, IMCR annual EBITDA has changed by +$21.76M (+42.13%)

What is Immunocore Holdings plc quarterly EBITDA?

The current quarterly EBITDA of IMCR is -$6.33M

What is the all-time high quarterly EBITDA for Immunocore Holdings plc?

Immunocore Holdings plc all-time high quarterly EBITDA is -$2.77M

What is Immunocore Holdings plc quarterly EBITDA year-on-year change?

Over the past year, IMCR quarterly EBITDA has changed by +$1.21M (+16.03%)

What is Immunocore Holdings plc TTM EBITDA?

The current TTM EBITDA of IMCR is -$41.49M

What is the all-time high TTM EBITDA for Immunocore Holdings plc?

Immunocore Holdings plc all-time high TTM EBITDA is -$28.61M

What is Immunocore Holdings plc TTM EBITDA year-on-year change?

Over the past year, IMCR TTM EBITDA has changed by +$24.64M (+37.26%)
On this page